Ordoñez, Victor D.

HRN: 29-02-90  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/24/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
05/24/2026
05/30/2026
IV
300 Mg
Q8h
Cellulits
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines